Betta Pharmaceuticals has a total of 977 patents globally, out of which 363 have been granted. Of these 977 patents, more than 52% patents are active. China is where Betta Pharmaceuticals has filed the maximum number of patents, followed by Taiwan and United States of America. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Betta Pharmaceuticals.
Betta Pharmaceuticals was founded in 2003. Betta Pharmaceuticals is a leading biopharmaceutical company focused on developing and producing innovative medicines. The company works to improve treatment options for serious diseases, especially in oncology and related areas. With advanced research and strong scientific expertise, Betta aims to deliver effective and reliable healthcare solutions.
Do read about some of the most popular patents of Betta Pharmaceuticals which have been covered by us in this article and also you can find Betta Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Betta Pharmaceuticals patent portfolio.
How many patents does Betta Pharmaceuticals have?
Betta Pharmaceuticals has a total of 977 patents globally. These patents belong to 198 unique patent families. Out of 977 patents, 512 patents are active.
How Many Patents did Betta Pharmaceuticals File Every Year?

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Betta Pharmaceuticals Applications Filed | Betta Pharmaceuticals Patents Granted |
| 2025 | 5 | 18 |
| 2024 | 27 | 44 |
| 2023 | 74 | 27 |
| 2022 | 116 | 23 |
| 2021 | 140 | 17 |
| 2020 | 94 | 15 |
| 2019 | 106 | 20 |
| 2018 | 31 | 35 |
| 2017 | 27 | 48 |
| 2016 | 31 | 51 |
How many Betta Pharmaceuticals patents are Alive/Dead?
Worldwide Patents

How Many Patents did Betta Pharmaceuticals File in Different Countries?

Countries in which Betta Pharmaceuticals Filed Patents
| Country | Patents |
| China | 183 |
| Taiwan | 71 |
| United States of America | 69 |
| Hong Kong (S.A.R.) | 54 |
| Europe (EPO) | 54 |
| Korea (South) | 49 |
| Japan | 47 |
| Australia | 42 |
| Canada | 39 |
| Singapore | 34 |
| Brazil | 22 |
| South Africa | 22 |
| Israel | 22 |
| India | 20 |
| Germany | 17 |
| Spain | 16 |
| Russia | 16 |
| Austria | 16 |
| Viet Nam | 11 |
| Mexico | 9 |
| Eurasia | 8 |
| New Zealand | 5 |
| Malaysia | 4 |
| Philippines | 4 |
| Macao | 3 |
| Italy | 1 |
| Denmark | 1 |
| Indonesia | 1 |
| Poland | 1 |
Where are Research Centers of Betta Pharmaceuticals Patents Located?

10 Best Betta Pharmaceuticals Patents
WO2013013609A1 is the most popular patent in the Betta Pharmaceuticals portfolio. It has received 126 citations so far from companies like Fibrogen, Dr. Reddy, Akebia Therapeutics.
Below is the list of 10 most cited patents of Betta Pharmaceuticals:
| Publication Number | Citation Count |
| WO2013013609A1 | 126 |
| WO2019192506A1 | 84 |
| WO2021121371A1 | 61 |
| WO2020156243A1 | 57 |
| WO2020156242A1 | 49 |
| WO2012006960A1 | 49 |
| WO2018153373A1 | 46 |
| WO2015003658A1 | 44 |
| WO2009154769A1 | 42 |
| WO2021147879A1 | 39 |
What Percentage of Betta Pharmaceuticals US Patent Applications were Granted?
Betta Pharmaceuticals (Excluding its subsidiaries) has filed 56 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 21 have been granted leading to a grant rate of 70%.
Below are the key stats of Betta Pharmaceuticals patent prosecution at the USPTO.

Which Law Firms are managing US Patents for Betta Pharmaceuticals?
| Law Firm | Total Applications | Success Rate |
| Umberg Zipser Llp | 12 | 80.00% |
| Foley & Lardner Llp | 8 | 83.33% |
| Greenberg Traurig Llp | 6 | 100.00% |
| Alston & Bird Llp | 5 | 0% |
| Clifford Chi A P C | 4 | 0.00% |
| Norton Rose Fulbright Us Llp | 4 | 0% |
| Seed IP Law Group Llp | 3 | 0% |
| Finnegan Henderson Farabow Garrett & Dunner | 2 | 100.00% |
| Howson & Howson Llp | 2 | 100.00% |
| Mccarter & English Llp | 2 | 50.00% |
| Rankin Hill & Clark Llp | 2 | 0.00% |
| Buchanan Ingersoll & Rooney Pc | 1 | 100.00% |
| Epa Bozicevic Field & Francis Llp | 1 | 0% |
| Hunton Andrews Kurth Llp | 1 | 100.00% |
| Katten Muchin Rosenman Llp | 1 | 0% |
What are Betta Pharmaceuticals key innovation segments?
What Technologies are Covered by Betta Pharmaceuticals?

The chart below distributes patents filed by Betta Pharmaceuticals in different countries on the basis of the technology protected in patents. It also represents the markets where Betta Pharmaceuticals thinks it’s important to protect particular technological inventions.

R&D Focus: How has Betta Pharmaceuticals search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Betta Pharmaceuticals?